Novus Capital is a leading regional investment banking firm in pharmaceutical industry with geographic focus on Russia, the CIS and the Baltic States. Novus Capital professionals have a broad experience in advising owners and foreign investors in M&A transactions and related activities (due diligence, structuring, negotiations etc.). In recent years our team executed a number of cross border transactions in pharmaceutical industry with total value of USD 450 m, making our team the leading financial adviser to pharmaceutical companies in Russia
Company Details
- Employees
- 15
- Founded
- -
- Address
- Federation Tower || Tower West, 41st Floor 12 Presnenskaya Nab., Moscow,123100,russian Federation
- Industry
- Investment Banking
- NAICS
-
Investment Banking and Securities Dealing
- Website
- http://www.novuscapital.ru
- HQ
- Moscow
Novus Capital Questions
Novus Capital's website is http://www.novuscapital.ru
Novus Capital's LinkedIn profile is https://ru.linkedin.com/company/novus-capital
Novus Capital has
15 employees.
View email and phone details for 15
employees at Novus Capital.
Novus Capital's industry is
Investment Banking
Novus Capital's top competitors are
Vtb Capital,
Sberbank Cib,
S8 Capital,
Novus Capital,
Novus Wealth,
Aspring Capital,
Renaissance Capital,
Rt Business Development Llc,
Nexus Capital,
Advance Capital.
Novus Capital's categories are Investment Banking
Novus Capital's founding year is 2015
